Renaissance Technologies - ELEDON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$85
+2.4%
61,973
+2.7%
0.00%
Q2 2023$83
+9.2%
60,373
+87.7%
0.00%
Q1 2023$76
+11.8%
32,173
+8.4%
0.00%
Q4 2022$68
-99.9%
29,673
-6.9%
0.00%
Q3 2022$88,000
+11.4%
31,873
-0.9%
0.00%
Q2 2022$79,000
+8.2%
32,173
+74.2%
0.00%
Q1 2022$73,000
+21.7%
18,473
+35.1%
0.00%
Q4 2021$60,000
-75.5%
13,673
-65.5%
0.00%
Q3 2021$245,000
+46.7%
39,663
+87.9%
0.00%
Q2 2021$167,000
-42.2%
21,107
-22.0%
0.00%
Q1 2021$289,00027,0510.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CM Management, LLC 225,000$549,0000.58%
BVF INC/IL 2,326,710$5,677,0000.27%
Cormorant Asset Management, LP 1,305,095$3,184,0000.24%
Ikarian Capital, LLC 362,537$884,0000.16%
JMAC ENTERPRISES LLC 54,538$133,0000.03%
Woodline Partners LP 516,675$1,261,0000.02%
Eversept Partners, LP 59,065$144,1190.01%
INGALLS & SNYDER LLC 51,149$125,0000.01%
Point72 Asset Management, L.P. 428,360$1,045,0000.00%
BAILARD, INC. 27,413$67,0000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders